CalciMedica, Inc. held its 2024 Annual Meeting where stockholders approved an amendment to increase the shares authorized under the 2023 Equity Incentive Plan by 1,500,000 shares, elected two Class I directors, and ratified the appointment of Moss Adams LLP as the independent auditor for 2024.